ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Race Oncology (RAC.AU)
Race Oncology share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Australian Securities Exchange · Australia
A$1.54▼ -6.69%
Prices as of Oct 27, 2026 · AUD
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Race Oncology in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Race Oncology
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Race Oncology a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between A$1.39 and A$1.67; in 9 out of 10, between A$1.19 and A$1.96. Estimated annual volatility is 45%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- A$303M
- Market cap (USD)
- $213M
- 52-week high
- A$3.79
- 52-week low
- A$1.52
- Revenue (12 months)
- A$2.8M
- Gross margin
- 61.2%
- Operating margin
- -370.1%
- Net margin
- 0.0%
- Beta
- 0.91
What this means
ATLAS does not publish a fair value for RAC.AU right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks RAC.AU has traded between A$1.52 and A$3.79. Today it is 59.5% below that high and 1% above its low.
Its beta is 0.91: it moves roughly in line with the market.
About the company
Racura Oncology Ltd operates as a clinical-stage biopharmaceutical company in Australia.
Want to see everything about Race Oncology?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Race Oncology do?
Racura Oncology Ltd operates as a clinical-stage biopharmaceutical company in Australia.
What is the chance RAC.AU goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, RAC.AU ends the month between A$1.39 and A$1.67.
How big is Race Oncology and what is its P/E ratio?
Race Oncology's market capitalization is A$303M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is RAC.AU?
ATLAS estimates annual volatility at 45%. In a typical month, half of the outcomes end between A$1.39 and A$1.67.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer